Rolfe Lindsey 4
4 · CERO THERAPEUTICS HOLDINGS, INC. · Filed Mar 6, 2025
Insider Transaction Report
Form 4
Rolfe Lindsey
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-03-04+17,923→ 17,923 totalExercise: $1.43Exp: 2035-03-03→ Common Stock (17,923 underlying)
Footnotes (1)
- [F1]Represents the 50% time-based portion of an award of options to purchase 35,846 shares, vesting on the twelve month anniversary of the grant date, with the remaining portion subject to performance conditions.